Net Profit: 29,03B kr 🟢 Expected: 27,8B kr
Revenues: 78,09B kr 🔴 Expected: 78,18B kr
Wegovy Sales: 17,36B kr 🔴 Expected: 18,51B kr
Ozempic Sales: 32,72B kr 🟢 Expected: 31,5B kr
Sales Growth: 13-21% 🟡 Expected: 16-24%
Operating Profit: 16-24% 🟡 Expected: 19-27%
EPS: 6,53 kr 🟢 Expected: 6,04 kr